Suchergebnisse - "Jouve, Thomas"

PubPharm (9)

1

Switching renal transplant recipients to belatacept therapy : results of a real-life gradual conversion protocol

enthalten in: Transplant immunology | 2019

von Malvezzi, P. | Fischman, C. | Rigault, G. | +6

2

An update on the safety of tacrolimus in kidney transplant recipients, with a focus on tacrolimus minimization

enthalten in: Expert opinion on drug safety | 2019

von Jouve, T. | Noble, J. | Rostaing, L. | +1

3

Belatacept in kidney transplantation and its limitations

enthalten in: Expert review of clinical immunology | 2019

von Noble, J. | Jouve, T. | Janbon, B. | +2

4

Desensitization in the Setting of HLA-Incompatible Kidney Transplant

enthalten in: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation | 2018

von Malvezzi, P. | Jouve, T. | Noble, J. | +1

5

Advagraf® with or without an induction therapy for de novo kidney-transplant recipients

enthalten in: Expert review of clinical immunology | 2018

von Noble, J. | Jouve, T. | Rostaing, L. | +1

6

Tailoring tacrolimus therapy in kidney transplantation

enthalten in: Expert review of clinical pharmacology | 2018

von Jouve, T. | Noble, J. | Rostaing, L. | +1

7

New formulations of tacrolimus and prevention of acute and chronic rejections in adult kidney-transplant recipients

enthalten in: Expert opinion on drug safety | 2017

von Jouve, T. | Rostaing, L. | Malvezzi, P.

8

Costimulation Blockade in Kidney Transplantation : An Update

enthalten in: Transplantation | 2016

von Malvezzi, P. | Jouve, T. | Rostaing, L.

CommentIn: Transplantation. 2022 Aug 1;106(8):e388-e390. - PMID 35881521

9

Use of Everolimus-based Immunosuppression to Decrease Cytomegalovirus Infection After Kidney Transplant

enthalten in: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation | 2016

von Malvezzi, P. | Jouve, T. | Rostaing, L.

1
[1]